on AI/ML Innovations Inc. (isin : CA00143Y1034)
AI/ML Innovations Inc. Welcomes Dr. Alan Rabinowitz as CMO
AI/ML Innovations Inc. has appointed Dr. Alan Rabinowitz as Chief Medical Officer and Director of Medical Partnerships. A renowned cardiologist and healthcare innovator, Dr. Rabinowitz will guide AI/ML's AI-driven healthcare solutions. He brings over 20 years of experience in clinical cardiology and healthcare strategy.
Dr. Rabinowitz held the position of Director at St. Paul's Hospital's Coronary Care Unit and is a Clinical Associate Professor at the University of British Columbia. His background includes leading ventures in advanced diagnostics and personalized medicine, integrating AI with cardiology for improved patient care.
Paul Duffy, CEO of AI/ML, applauded Dr. Rabinowitz's vision in cardiology and digital health. Mark Orsmond, Executive Chairman, emphasized the strategic role Dr. Rabinowitz will play in the company's digital health ambitions.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AI/ML Innovations Inc. news